ProRx LLC 2025-11-05 Health serious FDA
Health · FDA · Recall #FDA-D-0116-2026
Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use,… Recall
Issued November 5, 2025 · ProRx LLC
In November 2025, ProRx LLC recalled the Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of Assurance of Sterility
What you should do
- 1 Stop using Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact ProRx LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- ProRx LLC
- Category
- Health
- Recall date
- November 5, 2025
- Units affected
- Not reported
- Sold at
- TX and UT
- Recall number
- FDA-D-0116-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- ProRx LLC has 9 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.